Investment Highlights - The pharmaceutical index did not record any positive returns across six sub-industries this week [1] - Under the backdrop of tightening ESG regulations, the pharmaceutical manufacturing industry is accelerating the integration of sustainable development into core strategies, with a significant increase in report disclosure rates [2][7] - The industry has fully entered the innovative drug phase, with R&D expenditure in 2023 reaching 33,278 billion, a year-on-year increase of 8.1% [10] - Companies like Haier Biomedical are breaking international monopolies through high R&D investments, establishing a global model [10] Industry Trends - Green transformation has become a new growth point in response to environmental pressures, with companies like Jiangzhong Pharmaceutical and Health元 Pharmaceutical implementing water recycling and wastewater management systems to avoid production suspension penalties and achieve cost reduction [2][10] - The importance of product quality and data security is highlighted, with MSCI assigning a weight of 27.1% to these issues in the pharmaceutical manufacturing sub-industry [11] - Companies such as Kanglong Chemical are utilizing AI technology to shorten R&D cycles, while Mindray Medical has established a zero-leakage information security system [11] Market Performance - The pharmaceutical sector's performance from March 16 to March 21 shows that the top two sub-industries with the highest decline were Traditional Chinese Medicine II (-1.16%) and Biological Products (-1.79%), while the lowest were Pharmaceutical Commerce (-4.01%) and Medical Services (-4.32%) [14] - The valuation levels for the pharmaceutical sector indicate that Biological Products had the highest PE ratio at 84.41 times, while Traditional Chinese Medicine II had the lowest at 28.90 times [14] Regulatory Developments - The first dedicated Medical Device Law is set to be included in the 2026 legislative agenda, establishing a comprehensive regulatory framework for the entire lifecycle of medical devices [22] - The new law aims to enhance regulatory compliance and international standard alignment, significantly reducing costs for companies looking to expand internationally [22] Industry Insights - The meeting between Minister Wang Wentao and Eli Lilly's CEO highlighted the ongoing commitment to enhancing Sino-US economic relations, with Eli Lilly planning to invest an additional 3 billion in China over the next decade [21] - The annual work summary meeting for Hunan's biopharmaceutical and medical device industry emphasized the region's potential as a new pillar industry, with significant advancements in R&D capabilities and investment outcomes [25]

1. Report Industry Investment Ratings There is no information about industry investment ratings in the provided content. 2. Core Views of the Report - The ongoing conflict between the US and Iran is causing significant impacts on global financial and commodity markets. It has led to increased oil prices, reduced expectations of Fed rate cuts, and concerns about inflation and economic slowdown. - Different industries are affected differently by the geopolitical situation. Some industries, such as energy and metals, are more directly impacted by the conflict, while others, like agriculture, are also influenced by factors such as supply - demand dynamics and policy changes. - For most commodities, short - term price movements are highly volatile, and investors need to pay close attention to geopolitical developments, supply - demand changes, and cost factors. 3. Summary by Industry Macro - Financial Stock Index - **行情资讯**: News includes Iran's plan to levy tolls on the Strait of Hormuz, potential US military actions, Alibaba's revenue target, and the success of Lilly's new drug in clinical trials [2]. - **策略观点**: Amid the US - Iran conflict, oil prices are rising, Fed rate - cut expectations are weakening, and US bond yields are climbing. In China, exports are resilient, and PPI is narrowing. Investors should monitor the war situation and control risks [4]. Treasury Bonds - **行情资讯**: Treasury bond futures prices showed small changes on Thursday. Fiscal revenue data from January to February and Japan's central bank's interest - rate decision were reported. The central bank conducted 130 billion yuan of 7 - day reverse repurchase operations, resulting in a net withdrawal of 115 billion yuan [5]. - **策略观点**: Economic data in January - February improved, but the sustainability of economic recovery is uncertain. Inflation pressure may weigh on the bond market. The bond market is expected to be volatile and weak in the short term [6]. Precious Metals - **行情资讯**: Shanghai gold and silver prices declined, while COMEX gold and silver prices rose. Central banks around the world maintained interest rates, and the US issued a new license for Russian oil. The US and Israel's military actions against Iran continued [7]. - **策略观点**: The US - Iran war has made central banks vigilant about inflation. The Fed's decision to maintain interest rates and the stance of other central banks put pressure on precious metal prices. A cautious bearish strategy is recommended [8]. Non - Ferrous Metals Copper - **行情资讯**: Middle East conflicts led to a sharp decline and subsequent recovery in copper prices. LME inventory increased, while domestic social and bonded area inventories decreased. Spot premiums changed, and the scrap - refined copper price difference narrowed [10]. - **策略观点**: The risk of conflict escalation and high oil prices suppress sentiment. The supply of copper concentrate is tight, but domestic demand is improving. Copper prices need a more favorable macro environment to stabilize and rise [11]. Aluminum - **行情资讯**: Aluminum prices dropped due to the Middle East conflict. LME inventory decreased, and domestic downstream开工率 increased. Aluminum ingot and rod inventories changed, and spot premiums narrowed [12]. - **策略观点**: The risk of conflict escalation remains, but the suspension of attacks on Iran's energy facilities eases concerns. Overseas supply is still threatened, and domestic demand is improving. Aluminum prices are supported [13]. Zinc - **行情资讯**: Zinc prices declined. LME and domestic inventories, as well as basis and spreads, were reported. Social inventory decreased, and downstream buyers replenished stocks at low prices [14][15]. - **策略观点**: Zinc concentrate inventory increased slightly, and smelting profits are low. The industry is weak, and geopolitical conflicts and inflation concerns put pressure on zinc prices. Attention should be paid to inventory changes [15]. Lead - **行情资讯**: Lead prices fell. LME and domestic inventories, basis, and spreads were reported. Social inventory decreased [16]. - **策略观点**: Lead concentrate inventory decreased slightly, and smelting profits were affected. Downstream demand improved slightly, but the inflow of overseas inventory may suppress prices. Short - term prices are supported, but further declines are possible [16]. Nickel - **行情资讯**: Nickel prices declined. Spot premiums and cost factors were reported [17]. - **策略观点**: Supply from some Indonesian plants is expected to be tight, but geopolitical risks and high inventory levels may lead to price fluctuations. A high - sell and low - buy strategy is recommended [18]. Tin - **行情资讯**: Tin prices dropped. SHFE and LME inventories changed. Supply is in a post - holiday recovery phase, and demand is weak [19]. - **策略观点**: Supply is still tight, and demand is weakly recovering. Tin prices are expected to fluctuate in a wide range at high levels [20]. Lithium Carbonate - **行情资讯**: Lithium carbonate prices declined. Production and inventory data were reported [21]. - **策略观点**: The Iran situation affects metal prices. Supply and demand are both strong, and prices have some support. Attention should be paid to market changes [21]. Alumina - **行情资讯**: Alumina prices declined. Spot and futures prices, as well as basis, were reported [22]. - **策略观点**: The policy on bauxite exports in Guinea may affect prices. Supply is tightening in the short term but remains in a long - term surplus. A wait - and - see strategy is recommended [23]. Stainless Steel - **行情资讯**: Stainless steel prices declined. Spot and futures prices, as well as inventory data, were reported [24]. - **策略观点**: Geopolitical tensions and supply - demand dynamics lead to price volatility. Supply is increasing, and demand is mainly for rigid needs. Prices are expected to remain volatile [24]. Cast Aluminum Alloy - **行情资讯**: Cast aluminum alloy prices declined. Inventory and trading volume data were reported [25]. - **策略观点**: Cost support and improving demand may support prices in the short term [27]. Black Building Materials Steel - **行情资讯**: Steel prices were slightly down. Spot and futures prices, as well as inventory and trading volume data, were reported [29]. - **策略观点**: The real estate market is still weak, and steel demand is limited. The steel market is in a weak - balance state, and attention should be paid to demand release and raw material price changes [30]. Iron Ore - **行情资讯**: Iron ore prices declined slightly. Spot and futures prices, as well as basis and inventory data, were reported [31]. - **策略观点**: Overseas supply is fluctuating, and demand is recovering. Geopolitical conflicts and negotiation issues may cause price fluctuations. Attention should be paid to negotiation progress and geopolitical developments [33]. Coking Coal and Coke - **行情资讯**: Coking coal prices rose slightly, and coke prices fell slightly. Spot and futures prices, as well as basis and inventory data, were reported [34]. - **策略观点**: Coking coal prices are affected by energy sentiment, and coke prices follow coking coal. In the short term, demand is restricted by inventory, but there may be upward price impulses. In the long term, coking coal prices are expected to rise [38]. Glass and Soda Ash - **行情资讯**: Glass and soda ash prices declined. Spot and futures prices, as well as inventory and trading volume data, were reported [39][40]. - **策略观点**: Geopolitical tensions affect energy prices, which in turn impact glass and soda ash. Glass prices are expected to be volatile, and soda ash prices are expected to be weak in the short term [39][41]. Manganese Silicon and Ferrosilicon - **行情资讯**: Manganese silicon and ferrosilicon prices rose. Spot and futures prices, as well as basis and inventory data, were reported [42]. - **策略观点**: Geopolitical conflicts drive market sentiment. Manganese silicon has a loose supply - demand structure, while ferrosilicon has a better fundamental situation. Attention should be paid to cost and supply - side factors [44]. Industrial Silicon and Polysilicon - **行情资讯**: Industrial silicon prices declined, and polysilicon prices also dropped. Spot and futures prices, as well as inventory and trading volume data, were reported [46][48]. - **策略观点**: Industrial silicon has a weak supply - demand situation, and cost support is relatively strong. Polysilicon has a weak fundamental situation, and prices are under pressure [47][49]. Energy and Chemicals Rubber - **行情资讯**: The Middle East situation causes concerns about the economic outlook. Natural rubber has different views from bulls and bears. Tire enterprise开工率 and inventory data were reported [51][52]. - **策略观点**: The market is volatile, and a flexible trading strategy is recommended. Short - term trading with stop - loss is advised, and certain hedging positions can be held [53]. Crude Oil - **行情资讯**: Crude oil and related product prices rose. US inventory data were reported [54]. - **策略观点**: A bearish strategy for crude oil is recommended. Strategies such as widening price spreads and short - selling cracking spreads are proposed [56]. Methanol - **行情资讯**: Methanol prices changed. Spot and futures price data were reported [57]. - **策略观点**: Methanol already includes geopolitical premiums, and a profit - taking strategy is recommended [58]. Urea - **行情资讯**: Urea prices changed slightly. Spot and futures price data were reported [59]. - **策略观点**: The supply - demand situation is balanced, and a short - selling strategy is recommended. Attention should be paid to demand changes [60]. Pure Benzene and Styrene - **行情资讯**: Pure benzene and styrene prices changed. Cost, supply, demand, and inventory data were reported [61][62]. - **策略观点**: The profit of non - integrated styrene production is neutral to high. Supply is relatively abundant, and demand is improving. A wait - and - see strategy is recommended [63]. PVC - **行情资讯**: PVC prices rose. Cost, supply, demand, and inventory data were reported [64]. - **策略观点**: The enterprise's comprehensive profit is high, but there are expectations of production cuts and seasonal maintenance. Supply and demand are affected by geopolitical and export factors. Prices may rebound in the short term, but risks should be noted [65]. Ethylene Glycol - **行情资讯**: Ethylene glycol prices rose. Supply, demand, and inventory data were reported [66]. - **策略观点**: The industry is entering the maintenance season, and imports are expected to decline. Downstream demand is recovering, and inventory is expected to decrease. However, short - term price increases are significant, and risks should be noted [68]. PTA - **行情资讯**: PTA prices rose. Supply, demand, and inventory data were reported [69]. - **策略观点**: PTA is difficult to enter a de - stocking cycle, and processing fees are difficult to increase. PXN may rise, but short - term price increases are significant, and risks should be noted [70]. p - Xylene - **行情资讯**: PX prices rose. Supply, demand, and inventory data were reported [71]. - **策略观点**: PX load is expected to decline, and it is entering a de - stocking cycle. Valuation is expected to rise, but short - term price increases are significant, and risks should be noted [72]. Polyethylene (PE) - **行情资讯**: PE prices rose. Spot and futures prices, as well as supply, demand, and inventory data were reported [73]. - **策略观点**: Geopolitical conflicts affect prices. Supply pressure is relieved, and demand is improving. A short - selling strategy for the spread between different contracts is recommended [74]. Polypropylene (PP) - **行情资讯**: PP prices rose. Spot and futures prices, as well as supply, demand, and inventory data were reported [75]. - **策略观点**: Cost and supply - demand factors affect prices. Short - term price movements are dominated by geopolitical conflicts, and long - term price movements are affected by production and demand mismatches [76]. Agricultural Products Live Pigs - **行情资讯**: Pig prices continued to decline. Regional price data were reported [78]. - **策略观点**: The supply of live pigs is still high, and the support from secondary fattening is limited. The spot market may remain weak in the short term. A short - selling strategy for the near - term contracts is recommended, and a wait - and - see strategy for the far - term contracts [79]. Eggs - **行情资讯**: Egg prices were stable or rising. Regional price data were reported [80]. - **策略观点**: Egg supply is still high, and the price increase space and sustainability are uncertain. A short - selling strategy for the near - term contracts is recommended, and attention should be paid to cost factors for the far - term contracts [81]. Soybean and Rapeseed Meal - **行情资讯**: Forecasts of US crop planting areas, export data, and global soybean production and inventory data were reported [82]. - **策略观点**: The USDA report is neutral. Geopolitical factors cause price fluctuations, and a short - term wait - and - see strategy is recommended [84]. Oils and Fats - **行情资讯**: Policies and production, export, and inventory data of palm oil in Indonesia and Malaysia were reported [85]. - **策略观点**: Geopolitical factors drive oil prices up. In the medium term, oil prices are expected to rise [86]. Sugar - **行情资讯**: Import, production, and inventory data of sugar in China, India, and Thailand were reported [87]. - **策略观点**: The potential reduction in the sugar - making ratio in Brazil may lead to sugar production cuts. In China, the pressure of production increase is relieved, and sugar prices may rebound. A buying - on - dips strategy is recommended [89]. Cotton - **行情资讯**: Import, export, and inventory data of cotton were reported. The US production forecast and global inventory - consumption ratio were also reported [90]. - **策略观点**: The new import quota is a short - term negative factor for cotton prices. The medium - term price trend depends on downstream开机率. A wait - and - see strategy is recommended [91].

Company Ratings - Haitan International (1882) - Buy rating with a target price of HKD 30.00 [2] - Kangzhi Pharmaceutical (867) - Buy rating with a target price of HKD 19.30 [2] Core Insights - Haitan International is expected to maintain steady growth despite industry fluctuations, with a projected revenue of HKD 177.33 billion in 2025, a 10.0% year-on-year increase, and a net profit of HKD 33.01 billion, up 7.2% [7] - Kangzhi Pharmaceutical is returning to a rapid growth trajectory with a revenue increase of 9.9% to HKD 82.1 billion in 2025, driven by exclusive products and innovative drugs [12] Summary by Relevant Sections Haitan International - The company achieved record high performance in 2025, with revenue reaching HKD 177.33 billion and net profit at HKD 33.01 billion, reflecting a 10.0% and 7.2% year-on-year growth respectively [7] - All product lines showed positive growth, with Mars, Jupiter, and Changfei series revenues of HKD 113.17 billion, HKD 24.21 billion, and HKD 21.53 billion, representing year-on-year growth of 8.1%, 16.4%, and 8.9% respectively [8] - The overseas market is expected to be a major growth driver, with international sales increasing by 26.4% to HKD 76.02 billion, accounting for 42.9% of total revenue [9] - The target price is set at HKD 30, maintaining a buy rating, with projected revenues of HKD 195 billion, HKD 208 billion, and HKD 227 billion for 2026-2028 [10] Kangzhi Pharmaceutical - The company reported a revenue increase of 9.9% to HKD 82.1 billion in 2025, with exclusive and innovative drug revenues rising by 23.3% to HKD 56.1 billion [12] - Key product lines showed varied performance, with cardiovascular products up 2.4%, digestive and autoimmune products up 3.3%, and skin health products soaring by 73.2% [13] - The target price is set at HKD 19.3, with a buy rating, reflecting a 40.2% upside potential [14]

Group 1 - Investment Rating: Buy for Haitan International (1882) with a target price of HKD 30.00, and Buy for Kangzhe Pharmaceutical (867) with a target price of HKD 19.30 [2] - Haitan International is expected to achieve a revenue of HKD 177.33 billion in 2025, representing a year-on-year growth of 10.0%, and a net profit of HKD 33.01 billion, up 7.2% year-on-year [7][10] - Kangzhe Pharmaceutical's revenue is projected to increase by 9.9% to HKD 82.1 billion in 2025, with a notable growth in exclusive and innovative drug sales [12][14] Group 2 - Haitan International's overseas sales are expected to grow significantly, with a 26.4% increase year-on-year, contributing to 42.9% of total revenue [9] - Kangzhe Pharmaceutical's innovative products are anticipated to drive growth, with new drug approvals expected to significantly boost revenue in the coming years [13][14] - The report highlights the strategic importance of the "ICL+CRO" model for Aidi Kang Holdings, which aims to enhance its value proposition through integrated laboratory services [17][27] Group 3 - Haitan International's gross margin improved to 32.7%, benefiting from supply chain management and increased overseas sales [7] - Kangzhe Pharmaceutical's gross margin decreased to 71.5%, influenced by various factors including increased R&D expenses [12] - Aidi Kang Holdings reported a gross profit margin of 35.8% in 2025, with a focus on optimizing costs and enhancing operational efficiency [17][21] Group 4 - Haitan International's target price reflects a 12/11/10 times forecasted P/E ratio for 2026-28 [10] - Kangzhe Pharmaceutical's target price indicates a potential upside of 40.2% from its current price [14] - Aidi Kang Holdings is positioned to leverage its dual-platform strategy to capture growth in both diagnostic and drug development sectors [36][37]

Group 1: Fixed Income and Banking - The 2026 bond market is expected to perform better than anticipated, with a projected net issuance of around 20 trillion yuan, maintaining the same level as the previous year, and an increase in bank proprietary bond investments expected to reach 16 trillion yuan [2][8] - The anticipated policy interest rate cut of 10-20 basis points in 2026 is expected to lead to a corresponding decline in the Loan Prime Rate (LPR), with the 10Y government bond yield projected to fluctuate between 1.6% and 1.9% [2][8] - The credit investment strategy for March 2026 suggests a preference for medium-term duration strategies, with the M2 bank perpetual bonds showing significant outperformance compared to other bonds [9][10] Group 2: Media Industry - MiLian Technology has shown rapid revenue growth, with revenues increasing from 10.52 million yuan in 2022 to 19.17 million yuan in the first half of 2025, and a significant increase in average monthly active users by 45.81% year-on-year [14][15] - The company has expanded its application matrix, launching overseas market applications in 2024, which contributes to its growth potential in the online emotional market [14][15] - The platform fosters a vibrant user community through various interactive modes led by host users, enhancing user engagement and retention [15][16] Group 3: Pharmaceutical Industry - Yuan Dong Bio's revenue has grown from 162 million yuan in 2013 to 1.35 billion yuan in 2024, with a compound annual growth rate of 21.3%, driven by its anesthetic products and the strategic acquisition of Super Yang Pharmaceutical [18][19] - The company is focusing on innovative drug development, particularly in the CRBN molecular glue space, with its core product HP-001 showing Best-in-Class potential [18][19] - The internationalization of its anesthetic products is expected to contribute to revenue growth, with overseas sales increasing from 0.02 million yuan in 2017 to 0.25 million yuan in 2024 [20][21]

Group 1: Economic Performance - Industrial added value for January-February increased by 6.3% year-on-year, surpassing expectations by 1.1 percentage points[3] - Fixed asset investment (FAI) showed a cumulative year-on-year increase of 1.8%, against an expected decline of 2.7%[14] - Service sector production rose to 5.2% year-on-year, up 0.2 percentage points from the previous value[3] Group 2: Investment Trends - Infrastructure investment rebounded significantly, with broad infrastructure up 25.8% year-on-year and narrow infrastructure up 23.6%[4] - Manufacturing investment growth improved by 2.5 percentage points to 3.1%, with notable increases in electrical machinery and textiles[4] - Real estate investment saw a reduction in decline, improving by 6.1 percentage points to -11.1%[5] Group 3: Consumer Behavior - Retail sales (social retail) increased by 1.9 percentage points to 2.8% year-on-year, although cumulative growth declined by 0.9 percentage points[6] - Service retail continued to outperform goods retail, with a widening growth gap of 3.1 percentage points[6] - Key contributors to retail growth included home appliances and food, while automotive sales lagged[6] Group 4: Market Outlook - Economic performance in early 2026 exceeded expectations, suggesting a potential moderate recovery in equity markets[7] - The need for additional policies to support domestic recovery remains, particularly in light of geopolitical uncertainties and consumer demand fluctuations[7] - Risks include potential policy changes and unexpected economic downturns in the U.S.[8]

Tax Deduction Policies - Integrated circuit design companies and qualified software companies can deduct employee training expenses based on actual incurred amounts when calculating taxable income [2] - Airlines can deduct costs related to pilot training, flight training, crew training, and air security training as transportation costs before tax [2] - Nuclear power generation companies can deduct training costs for nuclear plant operators as part of their generation costs, provided these costs are separately accounted for [2] Advertising and Promotion Expenses - General enterprises can deduct advertising and promotional expenses up to 15% of their annual sales revenue; any excess can be carried forward to future tax years [5] - Special industries, such as cosmetics, pharmaceuticals, and non-alcoholic beverage manufacturing, can deduct up to 30% of their annual sales revenue for advertising and promotional expenses, with excess amounts also eligible for carryforward [5] - Tobacco companies are not allowed to deduct any advertising and promotional expenses from taxable income [5] Employee Education Expenses - Since January 1, 2018, companies can deduct employee education expenses up to 8% of total salary expenses when calculating taxable income; any excess can be carried forward to future tax years [6] Charitable Donations - Companies can deduct charitable donations made through recognized social organizations or government entities up to 12% of annual profit; amounts exceeding this limit can be carried forward for up to three years [8]

Core Viewpoint - The company Kailaiying (06821) has announced a plan to utilize idle self-owned funds for purchasing financial products, indicating a strategic move to optimize asset management and enhance returns [1] Group 1: Company Announcement - The company will hold its fifth board meeting on March 13, 2026, to review and approve the proposal regarding the use of idle self-owned funds [1] - The approved amount for purchasing short-term financial institution products is not to exceed 4.5 billion RMB (or equivalent foreign currency) [1] - The usage period for these funds is set to be within 12 months from the date of the board's approval, allowing for the funds to be recycled within the specified limit and timeframe [1]

Investment Rating - The report gives a "Buy" rating for Wanzhe Co., Ltd. (万泽股份) [1] Core Views - Wanzhe Co., Ltd. is positioned as a dual-business model focusing on "micro-ecological live bacteria products and high-temperature alloys," with strong growth potential in both sectors [5][7] - The company is expected to benefit from the booming commercial aviation engine market and the increasing demand for gas turbines, particularly in the context of AI data centers [8][9] Summary by Sections Company Overview - Wanzhe Co., Ltd. transitioned to a dual-business model in 2019, focusing on micro-ecological live bacteria products and high-temperature alloys [13] - The company has shown stable revenue growth since the transition, with a CAGR of 14.5% from 2019 to 2024 [16] Financial Analysis - The total revenue for Wanzhe Co., Ltd. is projected to reach 1,336 million yuan in 2025, with a year-on-year growth rate of 23.9% [6] - The net profit attributable to shareholders is expected to be 245 million yuan in 2025, reflecting a growth rate of 27.3% [6] - The company maintains a gross margin above 70%, with a slight decline due to the increasing share of lower-margin high-temperature alloy products [31] Micro-Ecological Live Bacteria Products - The micro-ecological live bacteria segment is expected to grow significantly, with the Chinese probiotic market projected to reach 180 billion yuan by 2028, growing at a CAGR of 8.8% from 2024 to 2028 [5][57] - Key products like "Jin Shuangqi" and "Ding Junsheng" have established strong market positions, with high gross margins around 90% [5][62] High-Temperature Alloy Business - The high-temperature alloy business is experiencing rapid growth, with revenues increasing from 7.2 million yuan in 2019 to an estimated 236 million yuan in 2024, representing a CAGR of 101% [5][51] - The company has a unique integrated capability in the production of high-temperature alloys, which is rare among private enterprises in China [41] Market Opportunities - The commercial aviation engine market in China is expected to exceed 2.6 trillion yuan over the next 20 years, with significant opportunities in both new deliveries and aftermarket services [8] - The gas turbine market is also expanding, driven by AI data center construction, creating a favorable environment for Wanzhe Co., Ltd. to capture market share [8][9] Profitability Forecast - The forecasted net profits for 2025, 2026, and 2027 are 245 million yuan, 326 million yuan, and 420 million yuan, respectively, with corresponding PE ratios of 93, 70, and 54 [9]

Reduction - Tianli Lithium Energy's shareholder, Anhui High-tech Investment New Materials Industry Fund, plans to reduce its holdings by up to 3% of the company's total share capital, which amounts to 3.5622 million shares, within three months after the announcement [1] - Hubei Broadcasting's shareholder, CITIC Guoan Information Industry Co., Ltd., intends to reduce its holdings by up to 11,371,400 shares, representing 1% of the company's total share capital, within three months after the announcement [1] Confirmation/Clarification/Denial - Guangxun Technology confirmed that recent online information regarding sample delivery, potential clients, large orders, revenue forecasts, technological breakthroughs, and production capacity is false [2] - Ningbo Construction holds a 32.3684% stake in Zhongjing Cloud Data Storage Technology (Beijing) Co., Ltd., and neither company is engaged in core computing power leasing; Zhongjing Cloud's main business is cabinet space rental [2] - True Love Home noticed media rumors about a potential acquisition and business change; the company confirmed its main business remains in the research, design, production, and sales of household textiles, primarily blankets, without significant changes [2] - Zhongfu Shenying stated that the release of its new carbon fiber product, SYT80 (T1200 grade), will not have a significant impact on the company's operating performance in the short term [2] Other - *ST Changyao received a decision from the Shenzhen Stock Exchange regarding the termination of its stock listing, with shares expected to resume trading on March 20, 2026, entering a delisting preparation period lasting fifteen trading days, with the last trading date anticipated to be April 10, 2026 [5] - ST Jinglan's stock price increased by 176.79% from January 23, 2026, to March 12, 2026, triggering multiple instances of abnormal trading fluctuations; the stock is under key monitoring by the Shenzhen Stock Exchange and will be suspended for investigation starting tomorrow [5] Performance - AVIC Heavy Machinery reported a revenue of 10.115 billion yuan for 2025, a year-on-year decrease of 2.32%, with a net profit attributable to shareholders of 609 million yuan, down 4.83% year-on-year [6]